Refunds, minus a $15 processing fee, will be granted for cancellations received at least 3 days prior to the program. Cancellations received within 3 days of the webinar will receive a credit toward a future MTMI program, minus the $15 processing fee. No refunds will be made after the webinar starts. MTMI reserves the right to cancel any scheduled program because of low advance registration or other reasons. MTMI’s liability is limited to a refund of any program tuition paid. WEBINAR ATTENDEES that cannot log in due to unsolvable technical issues beyond their control will be eligible for a full refund.
FREE Webinar - Understanding & Communicating Breast Density’s Impact on Risk Assessment
Free One-Credit Webinar
Location & Dates
- July 21. 2022 | 5:30 PM CT
- July 21. 2022 | 5:30 PM CT
All webinars are held in Central Time, see Time Zone Map Below
Overview
About this Webinar
Nearly half of women over age 40 in the U.S. have dense breast tissue. Dense breast tissue increases a woman's chances of getting breast cancer by four to six times and can conceals cancer on a mammogram. Women with dense breast tissue require both knowledge of their composition and a tailored approach to cancer screening to improve detection rates and reduce interval cancers. The majority of US states have mandated that women are notified if they have dense breast tissues in their mammogram results letters and together with a patient’s physician, technologists are often tasked with educating patients about their classification.
Educational Objectives
At the conclusion of this webinar, attendees will be able to:
- Discuss masking risk, missed cancers and the importance of supplemental screening and tests
- Understand the different density measurement types and how they affect lifetime risk scores
- Describe density AI tools and image enhanced letters for patient understanding and compliance
Schedule
- Masking Risks and the Importance of Supplemental Screening and Tests
- Cultural Respect, Cultural Competency and Diversity
- The impact of cultural and diversity on patient engagement
This activity is approved by ASRT for continuing education credit for Radiologic Technologist recognized by the ARRT and various states.
Audience
This webinar is for all interested in breast density's impact on risk assessment.
Faculty
Name
Dave Mezzoprete, BS
Dave Mezzoprete has over 30 years of experience in women's imaging and has held sales and sales management positions with several companies over that period of time. Dave sold Lorad/Hologic mammography units for many years before joining R2 Technology to introduce the first computer-aided-detection system for mammography into the market. Later Dave and was a digital mammography specialist for Fuji and helped to introduce the Fuji FCRm CR for mammography into the US. Recently Dave has teamed up again with many of the scientists from R2 Technology to bring Volpara Solutions Density, Dose, and Analytics products to market.
Credits
ASRT Category A
This program provides hours of Category A continuing education credit for radiologic technologists approved by ASRT and recognized by the ARRT and various licensure states. Category A credit is also recognized by CAMRT’s Continuing Education Credit Approval Program for CE credit in Canada. You must attend the entire program to receive your certificate of completion.
Time Zone
